WhichRecall
Class IIReported 2025-08-13

Duloxetine Delayed-Release Capsules, USP, 60mg, 1,000-count bottles, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-10.

Recalled by Breckenridge Pharmaceutical, Inc.

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit

Advertisement
Recall Number
D-0552-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-07-15
Reported
2025-08-13
Distribution
U.S Nationwide
Code Info
Lot: 230836C, Exp.: 02/28/2026
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement